Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Revenue

Atara Biotherapeutics had revenue of $17.58M in the quarter ending June 30, 2025, a decrease of -38.63%. This brings the company's revenue in the last twelve months to $188.67M, up 202.41% year-over-year. In the year 2024, Atara Biotherapeutics had annual revenue of $128.94M with 1,404.02% growth.

• Revenue (ttm): $188.67M
• Revenue Growth: +202.41%
• P/S Ratio: 0.66
• Revenue / Employee: $1,233,118
• Employees: 153
• Market Cap: 82.43M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	128.94M	120.37M	1,404.02%
Dec 31, 2023	8.57M	-55.00M	-86.51%
Dec 31, 2022	63.57M	43.23M	212.55%
Dec 31, 2021	20.34M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.